These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Population spectrum of ACADM genotypes correlated to biochemical phenotypes in newborn screening for medium-chain acyl-CoA dehydrogenase deficiency. Maier EM; Liebl B; Röschinger W; Nennstiel-Ratzel U; Fingerhut R; Olgemöller B; Busch U; Krone N; v Kries R; Roscher AA Hum Mutat; 2005 May; 25(5):443-52. PubMed ID: 15832312 [TBL] [Abstract][Full Text] [Related]
5. Sudden death in medium chain acyl-coenzyme a dehydrogenase deficiency (MCADD) despite newborn screening. Yusupov R; Finegold DN; Naylor EW; Sahai I; Waisbren S; Levy HL Mol Genet Metab; 2010 Sep; 101(1):33-9. PubMed ID: 20580581 [TBL] [Abstract][Full Text] [Related]
6. Ethnicity of children with homozygous c.985A>G medium-chain acyl-CoA dehydrogenase deficiency: findings from screening approximately 1.1 million newborn infants. Khalid JM; Oerton J; Cortina-Borja M; Andresen BS; Besley G; Dalton RN; Downing M; Green A; Henderson M; Leonard J; Dezateux C; J Med Screen; 2008; 15(3):112-7. PubMed ID: 18927092 [TBL] [Abstract][Full Text] [Related]
7. Newborn screening for medium chain acyl-CoA dehydrogenase deficiency: evaluating the effects on outcome. Dezateux C Eur J Pediatr; 2003 Dec; 162 Suppl 1():S25-8. PubMed ID: 14628139 [TBL] [Abstract][Full Text] [Related]
8. The first three years of screening for medium chain acyl-CoA dehydrogenase deficiency (MCADD) by newborn screening ontario. Kennedy S; Potter BK; Wilson K; Fisher L; Geraghty M; Milburn J; Chakraborty P BMC Pediatr; 2010 Nov; 10():82. PubMed ID: 21083904 [TBL] [Abstract][Full Text] [Related]
9. Newborn screening for inborn errors of metabolism: a systematic review. Seymour CA; Thomason MJ; Chalmers RA; Addison GM; Bain MD; Cockburn F; Littlejohns P; Lord J; Wilcox AH Health Technol Assess; 1997; 1(11):i-iv, 1-95. PubMed ID: 9483156 [TBL] [Abstract][Full Text] [Related]
10. Newborn screening by tandem mass spectrometry for medium-chain Acyl-CoA dehydrogenase deficiency: a cost-effectiveness analysis. Venditti LN; Venditti CP; Berry GT; Kaplan PB; Kaye EM; Glick H; Stanley CA Pediatrics; 2003 Nov; 112(5):1005-15. PubMed ID: 14595039 [TBL] [Abstract][Full Text] [Related]
11. Synthesis framework estimating prevalence of MCADD and sensitivity of newborn screening programme in the absence of direct evidence. Leal J; Wordsworth S; Oerton J; Khalid JM; Dezateux C; J Clin Epidemiol; 2014 Oct; 67(10):1131-8. PubMed ID: 24998633 [TBL] [Abstract][Full Text] [Related]
12. Dissection of biochemical borderline phenotypes in carriers and genetic variants of medium-chain acyl-CoA dehyrogenase deficiency: implications for newborn screening [corrected]. Maier EM; Pongratz J; Muntau AC; Liebl B; Nennstiel-Ratzel U; Busch U; Fingerhut R; Olgemöller B; Roscher AA; Röschinger W Clin Genet; 2009 Aug; 76(2):179-87. PubMed ID: 19780764 [TBL] [Abstract][Full Text] [Related]
13. Frequencies of inherited organic acidurias and disorders of mitochondrial fatty acid transport and oxidation in Germany. Hoffmann GF; von Kries R; Klose D; Lindner M; Schulze A; Muntau AC; Röschinger W; Liebl B; Mayatepek E; Roscher AA Eur J Pediatr; 2004 Feb; 163(2):76-80. PubMed ID: 14714182 [TBL] [Abstract][Full Text] [Related]
15. Expanded newborn screening: outcome in screened and unscreened patients at age 6 years. Wilcken B; Haas M; Joy P; Wiley V; Bowling F; Carpenter K; Christodoulou J; Cowley D; Ellaway C; Fletcher J; Kirk EP; Lewis B; McGill J; Peters H; Pitt J; Ranieri E; Yaplito-Lee J; Boneh A Pediatrics; 2009 Aug; 124(2):e241-8. PubMed ID: 19620191 [TBL] [Abstract][Full Text] [Related]
16. Neonatal screening for inborn errors of metabolism: cost, yield and outcome. Pollitt RJ; Green A; McCabe CJ; Booth A; Cooper NJ; Leonard JV; Nicholl J; Nicholson P; Tunaley JR; Virdi NK Health Technol Assess; 1997; 1(7):i-iv, 1-202. PubMed ID: 9483160 [TBL] [Abstract][Full Text] [Related]
17. Newborn screening for medium chain acyl-CoA dehydrogenase deficiency (MCADD) in the UK. Goddard P J Fam Health Care; 2004; 14(4):90-2. PubMed ID: 15453442 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and outcome of expanded newborn screening for metabolic diseases--report of 10 years from South-West Germany. Lindner M; Gramer G; Haege G; Fang-Hoffmann J; Schwab KO; Tacke U; Trefz FK; Mengel E; Wendel U; Leichsenring M; Burgard P; Hoffmann GF Orphanet J Rare Dis; 2011 Jun; 6():44. PubMed ID: 21689452 [TBL] [Abstract][Full Text] [Related]
19. Newborn screening for medium chain acyl CoA dehydrogenase deficiency. Leonard JV; Dezateux C Arch Dis Child; 2009 Mar; 94(3):235-8. PubMed ID: 18838415 [TBL] [Abstract][Full Text] [Related]
20. Reduced incidence of severe metabolic crisis or death in children with medium chain acyl-CoA dehydrogenase deficiency homozygous for c.985A>G identified by neonatal screening. Nennstiel-Ratzel U; Arenz S; Maier EM; Knerr I; Baumkötter J; Röschinger W; Liebl B; Hadorn HB; Roscher AA; von Kries R Mol Genet Metab; 2005 Jun; 85(2):157-9. PubMed ID: 15896661 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]